HRQoL

Related by string. HRQOL * * *

Related by context. All words. (Click for frequent words.) 81 HRQOL 78 HRQL 76 QoL 72 SGRQ 70 symptom severity 70 psychosocial functioning 69 EQ 5D 68 subscales 68 depressive symptomatology 67 BMI z 67 erection hardness 66 EORTC QLQ C# 66 psychiatric comorbidities 66 subscale scores 66 IBDQ 66 NIH CPSI 66 WOMAC pain 66 Health Assessment Questionnaire 65 sociodemographic characteristics 65 QOL 65 comorbidity 65 MMSE scores 65 MADRS score 65 Depressive symptoms 65 psychiatric morbidity 64 sociodemographic variables 64 somatic symptoms 64 neurocognitive functioning 64 Montgomery Åsberg Depression 64 neurocognitive function 64 subscores 64 MMSE score 64 depressive symptoms 64 psychiatric comorbidity 64 alexithymia 64 nondepressed 63 DLQI 63 Symptom severity 63 logistic regression analyzes 63 HDRS 63 % CI #.#-#.# [006] 63 CORE OM 63 comorbidities 63 subscore 63 LUTS 63 sociodemographic factors 62 depressive symptom 62 comorbid anxiety 62 logistic regression model 62 EDSS score 62 MetS 62 comorbid 62 multivariable analyzes 62 Symptom Checklist 62 univariate analyzes 62 WOMAC 62 psychosocial variables 62 Logistic regression analysis 62 comorbid conditions 62 multivariate analyzes 62 preoperative PSA 62 NYHA functional class 62 HADS 62 carotid IMT 62 HAM D# 61 ADAS cog 61 subclinical atherosclerosis 61 premorbid 61 Psoriasis Area 61 PANSS 61 ADCS CGIC 61 SF #v# 61 PSQI 61 Global Impression CGI 61 Expanded Disability Status 61 SELENA SLEDAI 61 Seattle Angina Questionnaire 61 Incontinence Impact Questionnaire 61 convergent validity 61 UPDRS motor 61 QIDS SR 61 DAS# [002] 61 Visual Analogue Scale VAS 61 bivariate analyzes 61 Secondary endpoints 61 euthymic patients 61 VFQ 61 P = .# 61 Physical Component 61 covariate 61 Scale EDSS 61 Secondary endpoints include 61 autonomic dysfunction 61 psychopathological symptoms 61 clinically meaningful improvements 61 nonfatal MI 61 Logistic regression 61 CPAP adherence 61 abdominal adiposity 60 Comorbidity 60 CDAI 60 posttest 60 APACHE II 60 tertiles 60 Distress Scale 60 psychometric properties 60 clinically meaningful improvement 60 hypertension diabetes mellitus 60 thyrotropin levels 60 biochemical recurrence 60 Outcomes Study 60 carotid stenosis 60 EDSS scores 60 intraobserver 60 Montgomery Asberg Depression 60 odds ratios ORs 60 highest tertile 60 APOE genotype 60 subthreshold depression 60 UPDRS 60 NIHSS 60 GH deficiency 60 Rating Scale MADRS 60 Socioeconomic status 60 comorbid depression 60 posttransplant 60 IIEF 60 HAQ DI 60 affective disorders 60 Brief Psychiatric 60 multivariable analysis 60 metabolic parameters 60 hip BMD 60 morbidity mortality 60 NIHSS score 60 PCWP 60 multivariable adjusted 60 affective psychoses 60 diabetes mellitus DM 60 Univariate analysis 60 liver histology 60 univariate analysis 60 psychiatric outpatients 60 ADAS Cog 60 salivary cortisol 59 Scale Cognitive Subscale 59 serologically active patients 59 Neuropsychiatric Inventory 59 HbA 1c levels 59 Severity Index PASI 59 extrapyramidal symptoms 59 lipid profiles 59 IPSS 59 tumor histology 59 Unified Parkinson Disease 59 WOMAC scores 59 serum lipid levels 59 p = .# [002] 59 euthymic 59 HAMD 59 point Likert scale 59 poststroke 59 Disease Activity 59 preintervention 59 International Prostate Symptom 59 Crohn Disease Activity 59 covariates 59 subclinical hypothyroidism 59 Primary endpoints 59 Rating Scale BPRS 59 Status Scale EDSS 59 antipsychotic prescribing 59 CFQ R 59 Secondary efficacy endpoints 59 Main Outcome Measures 59 adenotonsillectomy 59 IRLS 59 Functional Assessment 59 posttreatment 59 myocardial infarction MI 59 Subgroup analyzes 59 urinary symptoms 59 DAS# scores 59 inflammatory biomarkers 59 nondiabetic patients 59 % CI #.#-#.# [007] 59 Sociodemographic 59 HbA 1c 59 GH deficient 59 Erectile Function IIEF 59 logistic regression analysis 59 #OHD 59 lowest tertile 59 confidence interval CI 59 pain subscale 59 DAS# CRP 59 endometrial thickness 59 rhinoconjunctivitis 58 confidence intervals CIs 58 interobserver reliability 58 oxygen desaturation 58 dysthymia 58 Charlson comorbidity index 58 sociodemographic 58 multivariate logistic regression 58 % CI #.#-#.# [008] 58 OAB symptoms 58 perinatal outcomes 58 ADCS ADL 58 Fibromyalgia Impact Questionnaire 58 interrater reliability 58 function subscale 58 Mental Component 58 cognitive affective 58 symptomatic VTE 58 intact parathyroid hormone 58 subjective sleepiness 58 LV ejection fraction 58 PANSS total 58 Index CDAI 58 logistic regression models 58 oncologic outcomes 58 cardio respiratory fitness 58 NNT = 58 elevated ALT 58 dyspnoea 58 YMRS 58 prevalences 58 Score DAS 58 MMSE 58 HbA1C levels 58 dyspnea 58 arterial oxygen saturation 58 CLBP 58 Baseline characteristics 58 serum parathyroid hormone 58 schizophrenia schizoaffective disorder 58 FACIT 58 QRS duration 58 SRBD 58 confidence interval #.#-#.# 58 serum PTH 58 Multivariate analysis 58 HIV HCV coinfected 58 postintervention 58 postoperative AF 58 GERD symptom 58 residual platelet reactivity 58 suicide ideation 58 IRLS score 58 fractional anisotropy 58 bivariate analysis 58 shorter telomere length 58 exploratory endpoints 58 HF hospitalization 58 Scale EDSS score 58 nonobese 58 affective psychosis 58 atherogenic dyslipidemia 58 fasting insulin 58 venous thromboembolic disease 58 % CI #.#-#.# [003] 58 daytime alertness 58 dyslipidaemia 58 acute subacute 58 Epworth Sleepiness Scale 58 apnea hypopnea index 58 intima media thickness 58 atherothrombotic disease 58 nonfasting triglyceride levels 58 extensive metabolizers 58 daytime sleepiness 58 Glasgow Coma Scale 58 PANSS scores 58 Cronbach alpha 57 echocardiographic parameters 57 glycated hemoglobin HbA1c 57 serum vitamin D 57 nasal symptom 57 adenoma recurrence 57 recurrent venous thromboembolism 57 Stroke Scale 57 bronchial hyperresponsiveness 57 hemodynamic measurements 57 Index FSFI 57 hippocampal volume 57 atherothrombotic 57 Multivariate analyzes 57 anthropometric measures 57 QOL questionnaire 57 syndromic 57 T2DM 57 obstructive CAD 57 postoperative mortality 57 waist circumference WC 57 Score TOS 57 untreated psychosis 57 neurodevelopmental outcomes 57 Skin sterol 57 diabetes mellitus hypertension 57 chronicity 57 SCr 57 neurocognitive impairment 57 serum IGF 57 CVD mortality 57 prognostic variables 57 Rating Scale UPDRS 57 suicide attempters 57 hippocampal volumes 57 tipranavir r 57 Y BOCS 57 tertile 57 albumin excretion rate 57 comorbid disorders 57 morphometric vertebral fractures 57 Comorbid 57 interobserver 57 univariate 57 hydroxyvitamin D levels 57 Charlson Comorbidity Index 57 oxycodone CR 57 familial clustering 57 ejaculatory function 57 somatoform disorders 57 Female Sexual Function 57 angiographically 57 mortality morbidity 57 mRS 57 daytime somnolence 57 multiple logistic regression 57 BPRS 57 PSA nadir 57 neurodevelopmental outcome 57 asthma exacerbation 57 internalizing disorders 57 neurologic impairment 57 EDSS 57 COPD exacerbation 57 telomere lengths 57 androgen deficiency 57 diastolic pressures 57 co morbidities 57 index BMI 57 LV dysfunction 57 PsA 57 Main Outcome Measure 57 Erectile Function 57 subsyndromal depression 57 abnormal lipid 57 coronary calcification 57 hsCRP levels 57 chronic periodontitis 57 neuropsychiatric symptoms 57 #q# deletion syndrome 57 Cystic Fibrosis Questionnaire Revised 57 Acute Physiology 57 Regression analyzes 57 sd = 57 attain statistical significance 57 symptomatic intracerebral hemorrhage 57 PHQ 9 57 recurrent ischemia 57 Multiple logistic regression 57 Score DAS# 57 FeNO 57 CHADS2 57 serum folate concentrations 57 CDAI score 57 glycosylated hemoglobin levels 57 comorbid psychiatric 57 perioperative complications 57 SLNB 57 meta regression 57 radical prostatectomy RP 57 arterial thickening 57 microalbuminuria 57 BPS IC 57 enthesitis 57 QT intervals 57 virologic response 57 abdominal pain abdominal discomfort 57 cardiometabolic risk 57 % CI #.#-#.# [005] 57 hematologic parameters 57 multivariate adjustment 57 histological subtype 57 PSADT 57 recurrent VTE 57 colorectal adenoma 57 baseline HbA1c 56 femoral neck BMD 56 urodynamic parameters 56 VaD 56 NATRECOR ® 56 Depression Scale 56 CONCERTA ® 56 IELT 56 pulmonary capillary wedge 56 IPAH 56 postdischarge 56 Apgar scores 56 CHD mortality 56 definite stent thrombosis 56 Negative Syndrome 56 nasal obstruction 56 aneurysmal subarachnoid hemorrhage 56 neurocognitive deficits 56 lifetime abstainers 56 CI = 56 Score IPSS 56 nmol L. 56 carotid intima media 56 analgesic efficacy 56 decrements 56 p = .# [001] 56 vasomotor 56 systolic function 56 SSRI SNRI 56 tic severity 56 histologic 56 bivariate 56 Systems HCAHPS 56 BPH symptom 56 Secondary endpoints included 56 Visual Analog Scale 56 Endothelial function 56 elevated creatinine 56 reflux symptoms 56 multivariate Cox 56 virological response 56 dyspareunia 56 NHANES III 56 cTnT levels 56 Univariate 56 Scale PANSS 56 erythrocyte sedimentation rate 56 prognostic factors 56 % Confidence Interval 56 spirometric 56 acromegalic patients 56 coronary stenosis 56 CANCIDAS 56 nulliparous women 56 inhaled corticosteroid therapy 56 HRCT 56 CIMZIA TM certolizumab pegol 56 secondary efficacy endpoint 56 Bonferroni correction 56 Hamilton Rating Scale 56 pain catastrophizing 56 plasma cortisol 56 urinary N telopeptide 56 Outcome Measures 56 OSDI 56 nonpsychotic 56 femoral neck fracture 56 RLS symptoms 56 LVEF 56 Non inferiority 56 schizophreniform disorder 56 cotinine levels 56 atrophic gastritis 56 gait disturbance 56 serum cotinine 56 clinico pathological 56 intracranial stenosis 56 antibody titer 56 PASI scores 56 State Examination MMSE 56 pCR 56 emotional lability 56 Suicidal ideation 56 Alzheimer Disease Assessment 56 Cognitive impairment 56 left ventricular diastolic 56 Pain Intensity 56 perceptual reasoning 56 prespecified secondary 56 pulmonary exacerbations 56 adnexal mass 56 probands 56 CR nPR 56 Neuroticism 56 CIBIC + 55 Dyspnea 55 hemodynamic parameters 55 HbA1c levels 55 TEAEs 55 nonexposed 55 ± SD 55 chi ^ sup 55 elevated LDH 55 Kaplan Meier analysis 55 urinary tract symptoms 55 retrospective cohort 55 myocardial infarction stroke 55 socio demographic 55 Child Behavior Checklist 55 peak VO2 55 p = #.# [002] 55 CNS LS 55 habitual snoring 55 p = #.# [003] 55 subsyndromal 55 URTI 55 postoperative complication 55 prognostic indicators 55 urolithiasis 55 George Respiratory Questionnaire 55 vasomotor symptoms 55 carotid artery narrowing 55 TT genotype 55 comorbid illnesses 55 vesicoureteral reflux 55 neurodevelopmental impairment 55 MADRS 55 cognitive domains 55 acute cholecystitis 55 RE LY ® 55 desvenlafaxine succinate 55 HbA 1C 55 systolic dysfunction 55 AST ALT 55 comorbid psychiatric disorders 55 HOMA IR 55 myocardial viability 55 Meta analyzes 55 androgen suppression 55 glycosylated hemoglobin HbA1c 55 = #.#-#.# 55 parkinsonism 55 thromboprophylaxis 55 guideline concordant 55 ziprasidone 55 serum concentrations 55 handgrip strength 55 prospective cohort 55 dietary calcium intake 55 clinically meaningful reductions 55 Postoperative 55 postoperative radiotherapy 55 demonstrated clinically meaningful 55 antioxidant supplementation 55 Poisson regression 55 preoperatively 55 T1DM 55 prepregnancy BMI 55 anovulatory infertility 55 confounders 55 coinfected patients 55 anemia hemoglobin 55 hepatic lesions 55 atopic 55 clinicopathological features 55 conditional logistic regression 55 Breslow thickness 55 menopausal symptom 55 platelet reactivity 55 adverse cytogenetics 55 lipid parameters 55 Insulin sensitivity 55 Depressive Symptoms 55 ANCOVA 55 airflow obstruction 55 glycated hemoglobin levels 55 biopsy Gleason 55 adiponectin concentrations 55 autistic traits 55 dichotomized 55 chronic prostatitis chronic 55 perioperative mortality 55 Mini Mental 55 CI #.#-#.# [001] 55 interindividual variability 55 triacylglycerol concentrations 55 premenstrual dysphoric disorder 55 EGFR mutation status 55 plasma folate 55 Nesiritide 55 prospectively stratified 55 serum ferritin 55 premenopause 55 allele frequencies 55 intraclass correlation coefficients 55 NSTEMI 55 CCyR 55 obstructive coronary artery 55 multivariable adjustment 55 #OHD levels 55 serum phosphate 55 amnestic MCI 55 Heavy menstrual bleeding 55 explanatory variables 55 percutaneous vertebroplasty 55 artery stenosis 55 6MWD 55 left ventricular systolic 55 parasitological 55 systolic BP 55 somatization disorder 55 cerebral oxygenation 55 beta blocker therapy 55 erectile function 55 NATRECOR R 55 Subgroup analysis 55 Operative mortality 55 aminotransferases 55 multivariable logistic regression 55 limiting generalizability 55 syndromal 55 Neuropsychiatric Inventory NPI 55 albumin excretion 55 pharmacokinetics PK 55 psychoeducation 55 dysphoric 55 psychosocial distress 55 prostate cancer CaP 55 cortical atrophy 55 % CI #.#-#.# [004] 55 serum lipid 55 CI -#.# 55 white matter hyperintensities 55 tibiofemoral 55 Preoperatively 55 ragweed allergic 55 concomitant medications 55 estimated glomerular filtration 55 acetabular dysplasia 55 Sleep disturbances 55 airway responsiveness 55 serum BDNF 55 randomized controlled trials RCTs 55 QTc interval 55 nutrient intakes 55 ALSFRS R 55 aged ≥ 55 coronary artery calcification 55 glycated hemoglobin 55 Postoperatively 55 FEV ^ sub 55 Cardiorespiratory fitness 54 UPDRS Part III 54 β = 54 Major depressive disorder 54 myocardial reperfusion 54 baseline A1C 54 cognitive function 54 secondary endpoint 54 cardiorespiratory fitness 54 generalized anxiety disorder GAD 54 juvenile idiopathic arthritis JIA 54 orofacial clefts 54 salmeterol fluticasone propionate 54 mean ± SEM 54 nonfatal myocardial infarction MI 54 nighttime awakenings 54 tiotropium 54 impaired glucose metabolism 54 #.#ng/ml 54 serum selenium 54 advanced neoplasia 54 metabolite concentrations 54 metabolic syndrome MetS 54 nonvertebral fracture 54 impaired cognition 54 atrioventricular block 54 ejaculatory control 54 colorectal neoplasia 54 Ocular Surface Disease 54 nonfatal myocardial infarction 54 macrovascular disease 54 Socio demographic 54 periprocedural 54 postoperative pulmonary 54 Heritability 54 left ventricular LV 54 nonsignificant 54 nonpregnant women 54 prolactin elevation 54 QALYs 54 prospectively defined 54 alanine aminotransferase 54 haematologic 54 cranial irradiation 54 urine albumin 54 Global Impression 54 Index HAQ DI 54 postoperative morbidity 54 2D 4D ratio 54 attention-deficit/hyperactivity disorder ADHD 54 CRQ 54 cardiac autonomic 54 CYP#D# genotype 54 transaminase levels 54 CIN3 54 Multivariate logistic regression 54 serum estradiol 54 clinicopathological 54 overactive bladder symptoms 54 Oswestry Disability Index 54 unpaired t 54 ‰ ¥ 54 seropositivity 54 alfuzosin 54 Treatment Outcome 54 pathologic fractures 54 symptomatology 54 interpersonal psychotherapy 54 CI #.#-#.# [002] 54 juvenile idiopathic arthritis 54 hypovitaminosis D 54 subclinical hyperthyroidism 54 Scale cognitive subscale 54 vertebral fracture 54 hydroxyvitamin D concentrations 54 pulmonary dysfunction 54 mIU L 54 microscopic hematuria 54 prospective multicenter study 54 serum lipids 54 MADIT CRT trial 54 elevated triglyceride levels 54 serum cortisol 54 BEXXAR Therapeutic Regimen 54 actigraphy 54 body habitus 54 electrophysiologic 54 nasal polyposis 54 nonvertebral fractures 54 plain radiographs 54 VLBW 54 meta analytic review 54 comorbid diagnoses 54 plasma homocysteine 54 CC genotype 54 psoriatic arthritis PsA 54 demographic variables 54 5 HTTLPR genotype 54 venlafaxine XR 54 voiding dysfunction 54 serum testosterone 54 CP CPPS 54 serum PSA 54 CHD CVD 54 cardiovascular disease CVD 54 urodynamic 54 subclinical cardiovascular disease 54 neurologic outcomes 54 serum folate 54 polyarticular 54 ACR Pedi 54 hsCRP 54 death reinfarction 54 subtrochanteric 54 waist girth 54 nonmetastatic prostate cancer 54 homocysteine concentrations 54 ALS Functional 54 locoregional 54 atheroma volume 54 corrected QT interval 54 hepatic cirrhosis 54 primary aldosteronism 54 Abnormal Involuntary Movement 54 Injury Severity Score 54 mL/min/#.# m 2 54 lymphocyte count 54 FACIT Fatigue 54 CTEPH 54 neuropsychological deficits 54 pulmonary infiltrates 54 neurobehavioural 54 Calcium intake 54 poststroke depression 54 pharmacodynamic parameters 54 mucosal inflammation 54 TNSS 54 UPDRS scores 54 BILAG 54 mesalamine granules 54 rheumatoid factor 54 preoperative 54 FluCAM arm 54 rebleeding 54 bulimia nervosa 54 troponin T 54 fasting plasma 54 plasma homocysteine levels 54 certolizumab 54 Erectile function 54 body fatness 54 atypical antipsychotic medications 54 cirrhotic patients 54 renal artery stenosis 54 non menstrual pelvic 54 parous women 54 diabetes hypertension hyperlipidemia 54 underwent coronary angiography 54 aspartate aminotransferase AST 54 carotid artery intima media 54 lumbar spine BMD 54 baseline PASI 54 recurrent miscarriage 54 Severity MSCS score 54 androgen deprivation 54 carotid artery stenting CAS 54 atopic disorders 54 aortic atherosclerosis 54 bacterial prostatitis 54 fasting triglyceride levels 54 arterial thromboembolic events 54 socioeconomic variables 54 MSLT 54 salivary flow 54 hepatorenal syndrome 54 pretransplant 54 ipsilateral stroke 54 gait disturbances 54 dysthymic disorder 54 retrospective observational study 54 urine NGAL 54 proband 54 deep venous thromboses 54 isolated systolic hypertension 54 tHcy concentrations 54 prolactin levels 54 Framingham Offspring 54 diastolic hypertension 54 hemoglobin A1c HbA1c 54 renal scarring 54 socioeconomic status SES 54 coronary artery calcium 53 atopy 53 neurologic sequelae 53 perimenopausal women 53 CIN2 + 53 ICD therapy 53 extracapsular extension 53 Venous thromboembolism 53 histological subtypes 53 neurological abnormalities 53 fragility fracture 53 Recurrence Score 53 Lumbar spine 53 analgesic medications 53 systolic hypertension 53 somatoform disorder 53 anogenital distance 53 CIMZIA ™ 53 Mood disorders 53 BMI waist circumference 53 nonadherence 53 Hamilton Anxiety Scale 53 de novo AML 53 IBS symptoms 53 Severity Index 53 internalizing behaviors 53 unfavorable cytogenetics 53 ejection fractions 53 neuropsychological assessment 53 hypoglycemic events 53 divalproex sodium 53 nmol l 53 noncardiac 53 Multiple linear regression 53 neurocognition 53 hyper IgE syndrome 53 glomerular filtration 53 Likert 53 Natalizumab 53 hypochondriasis 53 macroalbuminuria 53 SDQ 53 psychiatric inpatients 53 hyperlipidemia hypertension 53 Prehypertension 53 serum cotinine levels 53 linear regression analyzes 53 antenatal depression 53 eNO 53 medication nonadherence 53 Kaplan Meier curves 53 chlamydial infection 53 MDRD 53 generalized estimating 53 QTc prolongation 53 predictive validity 53 mammographic density 53 pelvic lymphadenectomy 53 undergoing CABG 53 ratio WHR 53 Kaplan Meier curve 53 EPDS 53 beta carotene supplementation 53 hyperlipidaemia 53 ADHD RS 53 Geriatric Depression 53 plasma triglycerides 53 nonfasting 53 neonatal morbidity 53 μg L 53 somatization 53 mg BID dose 53 Thrombolysis 53 progression TTP 53 QTc 53 CIBIC Plus 53 lipid lowering agents 53 cognitive functioning 53 severe exacerbations 53 lopinavir r arm 53 chromium picolinate supplementation 53 baseline FEV 53 contrast echocardiography 53 unmeasured confounders 53 systemic embolism 53 triglyceride concentrations 53 nodal metastases 53 cyclic HMB 53 virologic responses 53 hyperactivity inattention 53 hypogonadal 53 nonpsychiatric 53 dysmenorrhea 53 biochemical relapse 53 polyp recurrence 53 ventricular tachyarrhythmia 53 Renal Cell Carcinoma RCC 53 Descriptive statistics 53 HSCT 53 hemoglobin A1C 53 anal incontinence 53 thromboembolic complications 53 neuropsychological impairments 53 thromboembolic 53 RoACTEMRA 53 methotrexate monotherapy 53 Erythropoietic therapies may 53 hallux valgus 53 postmenopausal osteoporotic women 53 undergoing coronary angiography 53 euthyroid 53 seminal vesicle invasion 53 ADHD symptoms 53 cerebrovascular accident 53 bioavailable testosterone 53 prostate cancer PCa 53 tapentadol IR 53 lupus anticoagulant 53 retrospective cohort study 53 TAXUS Express Stent 53 systolic diastolic 53 x ULN 53 semiquantitative 53 hemodynamics 53 arterial stiffness 53 Structured Clinical 53 chest radiographs 53 antidiabetic medication 53 5 HTTLPR 53 serum prostate 53 Likert scale 53 ORTHO EVRA R 53 BMI percentiles 53 QTc intervals 53 Exclusion criteria 53 procedural sedation 53 adverse perinatal 53 acute myocardial infarction AMI 53 Depression Rating Scale 53 CIBIC plus 53 puerperal psychosis 53 Global Impression Severity 53 neuropsychological functioning 53 REYATAZ r arm 53 serum creatinine levels 53 Cognitive behavioral 53 polytherapy 53 hyperhomocysteinemia 53 maximal treadmill 53 gastroduodenal 53 hip circumference 53 thrombotic complications 53 perioperatively 53 neuropsychological assessments 53 Pearson correlation coefficient 53 allergic rhinitis AR 53 -#.# ± [002] 53 Visual acuity 53 sensitivity specificity 53 recurrent DVT 53 periprocedural MI 53 hypoglycaemic episodes 53 Aggrenox ® 53 cervicitis 53 ALT flares 53 reflux esophagitis 53 noncardiovascular mortality 53 β blockers

Back to home page